companiesSEC EDGAR
Transcode Therapeutics, Inc.

SEC EDGAR published this disclosure on 2026-07-20. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001104659-26-085107
cik1829635
company nameTranscode Therapeutics, Inc.
form424B3